Asthma Improvements Do Not Persist When Long-Term Therapy Is Stopped

Findings published in the May Journal of Pediatrics suggest that improvements in asthma control and airway responsiveness achieved during long-term treatment with budesonide or nedocromil do not persist when treatment is discontinued. The Childhood Asthma Management Program (CAMP), a randomized trial comparing three treatments for mild to moderate asthma over 4.3 years, showed that budesonide and nedocromil improved asthma control compared to placebo. . read more.